Ascentage Pharma Group International (AAPG) Total Current Liabilities: 2023-2025
- Ascentage Pharma Group International's Total Current Liabilities was N/A to $171.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $171.3 million, marking a year-over-year change of. This contributed to the annual value of $159.8 million for FY2024, which is 20.91% up from last year.
- Per Ascentage Pharma Group International's latest filing, its Total Current Liabilities stood at $171.3 million for Q2 2025, which was up 7.20% from $159.8 million recorded in Q4 2024.
- Over the past 5 years, Ascentage Pharma Group International's Total Current Liabilities peaked at $171.3 million during Q2 2025, and registered a low of $129.7 million during Q4 2023.
- Over the past 3 years, Ascentage Pharma Group International's median Total Current Liabilities value was $159.8 million (recorded in 2024), while the average stood at $153.6 million.
- Data for Ascentage Pharma Group International's Total Current Liabilities shows a peak YoY grew of 23.18% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Ascentage Pharma Group International's Total Current Liabilities stood at $129.7 million in 2023, then climbed by 23.18% to $159.8 million in 2024, then reached $171.3 million in 2025.
- Its last three reported values are $171.3 million in Q2 2025, $159.8 million for Q4 2024, and $129.7 million during Q4 2023.
